%0 Journal Article
%T Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey
%A A-Yan Mao
%A Bing-Bing Song
%A Dian Shi
%A Guo-Xiang Liu
%A Hui-Yao Huang
%A Ji-Yong Gong
%A Jian-Song Ren
%A Jie He
%A Jin-Yi Zhou
%A Ju-Fang Shi
%A Kai Zhang
%A Lan-Wei Guo
%A Le Wang
%A Li Lan
%A Lin Zhu
%A Ling Mai
%A Ling-Bin Du
%A Min Dai
%A Ni Li
%A Pei-An Lou
%A Qi Zhou
%A Rong Cao
%A Xian-Zhen Liao
%A Xiao Qi
%A Xiao-Hua Sun
%A Xiao-Jie Sun
%A Xin-Yu Zhu
%A Ya-Na Bai
%A Ying Ren
%A Yu-Qin Liu
%A Yuan-Zheng Wang
%J Archive of "Cancer Communications".
%D 2017
%R 10.1186/s40880-017-0209-4
%X The increasing prevalence of colorectal cancer (CRC) in China and the paucity of information about relevant expenditure highlight the necessity of better understanding the financial burden and effect of CRC diagnosis and treatment. We performed a survey to quantify the direct medical and non-medical expenditure as well as the resulting financial burden of CRC patients in China
%K Colorectal neoplasms
%K Direct expenditure
%K Financial burden
%K China
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410077/